November 29, 2017 / 1:09 AM / a year ago

Allergan hit with antitrust case over efforts to maintain Restasis sales

Drugmaker Allergan Plc on Monday was hit with a proposed class action lawsuit alleging it engaged in a pattern of anticompetitive conduct to prolong its monopoly on the dry eye medicine Restasis. The law firms Hilliard & Shadowen and Shepherd Finkelman Miller & Shah sued Allergan in U.S. District Court in Marshall, Texas, on behalf of a proposed class of individuals and groups that purchased Restasis indirectly after May 2014.

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below